Forehead EEG test may spot cognitive fatigue in MS

Credibility

Interest

Key Takeaway

A simple EEG measure over the forehead (frontal aperiodic exponent) may give an objective sign of cognitive fatigue in people with MS and Long COVID.

What They Found

Researchers measured brain electrical activity at rest and looked at a number called the 'aperiodic exponent' that reflects the balance between brain excitation and inhibition; lower values were linked with more cognitive tiredness. People who reported being very mentally fatigued—whether they had MS or Long COVID—showed lower frontal exponent values than people without fatigue. This difference was specific to the frontal brain area (the forehead region) and was not seen in the back of the head (occipital area), suggesting a regional change rather than a whole-brain effect. The frontal exponent helped predict who was fatigued even after accounting for age and depression, and it improved the accuracy of classifying fatigue with good sensitivity (catching true cases) and specificity (avoiding false alarms). Because this measure is objective and can be read from a routine EEG, it could be used alongside patient reports to track fatigue over time or to group people for treatment trials.

Who Should Care and Why

People with MS should care because cognitive fatigue is common and hard to measure, and this EEG marker could give a clear, objective sign that complements how you feel. Caregivers may find it useful because it offers a concrete test to help explain fatigue when symptoms are invisible, much like a thermometer confirms a fever. Clinicians and therapists can use this marker to track whether a treatment is helping mental tiredness, similar to using a blood pressure reading to follow heart meds. Researchers will benefit because the marker appears in both MS and Long COVID, meaning it could help develop treatments that work across conditions rather than only for one disease. Overall, this could affect daily life by providing evidence for fatigue that supports treatment decisions, workplace adjustments, or disability documentation.

Important Considerations

This study is cross-sectional, meaning it measured people at one time point, so we can't say the EEG change causes fatigue or will change if fatigue improves. The sample, while reasonably sized, needs replication in larger and more diverse groups before the test is used widely in clinics. Also, an EEG reading can be affected by things like medicines, sleep, or other health issues, so results must be interpreted together with clinical judgment and patient reports.

Categories:

MS Diagnostics Specific Symptoms Early Research

Article Topics:

EEG biomarkerLong COVIDaperiodic exponentexcitation/inhibition balancefatiguemultiple sclerosis

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Psychological medicine often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News